Compare Fortinet Inc (FTNT) vs Smith & Nephew plc (SNN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Fortinet Inc vs Smith & Nephew plc — how do they compare? Fortinet Inc trades at $161.48 (market cap $120.53B), while Smith & Nephew plc trades at $31.28 (market cap $12.81B). The key difference: Fortinet Inc is far larger — about 9.4× Smith & Nephew plc's market cap, and Smith & Nephew plc pays a 2.54% dividend while Fortinet Inc pays none. Which is the better fit depends on your goals.
| FTNT | SNN | |
|---|---|---|
Market Cap | $120.53B | $12.81B |
Sector | Technology | Health |
52-Week High | $166.83 | $38.70 |
52-Week Low | $74.39 | $28.73 |
Enterprise Value | $117.73B | $15.58B |
Dividend Yield | — | 2.54% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Fortinet (FTNT) trades at $161.46, down 3.22% today, but maintains a bullish technical signal with strong moving averages and support near $162. The company reported consistent earnings beats, with Q1 2026 EPS of $0.82 surpassing the $0.619 estimate, and demonstrates robust fundamentals including 80.3% gross margins and 27.49% net income margin. Recent news highlights AI-driven cybersecurity demand as a growth catalyst, with Fortinet expanding its FortiEndpoint platform for AI security (GlobeNewsWire, July 14, 2026).
Outlook is positive due to AI cybersecurity tailwinds and earnings momentum, but high valuation ratios (P/E of 63.76, P/S of 17.5) pose risks if growth slows. Analyst consensus is mixed with 42.65% buy ratings, though the $123.16 price target suggests caution relative to current levels. Key risks include competitive pressures and reliance on enterprise IT spending cycles.
Smith & Nephew (SNN) trades at $31.41, up 5.28% today, with a bullish technical signal from moving averages. The company shows improving fundamentals with revenue growth from $5.8B in 2024 to $6.2B projected for 2025 and net income margin expanding to 10.14%. Recent product launches in robotics and wound care, plus a $500M share buyback, highlight strategic execution. Analyst consensus is mixed with 27% buy ratings but 68% hold, reflecting cautious optimism amid earnings volatility where two of the last four quarters missed expectations.
Outlook: SNN's recovery trajectory and product innovation support long-term growth, but investor patience is needed due to earnings inconsistency and moderate debt levels. Key risks include competitive pressures in medtech and execution on guidance. The stock presents a value opportunity if operational improvements continue, trading at reasonable valuations (P/E 21.5, P/S 2.18) versus sector peers.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Fortinet Inc
Fortinet is a cybersecurity vendor that sells products, support, and services to small and midsize businesses, enterprises, and government entities. Its products include unified threat management appliances, firewalls, network security, and its security platform, Security Fabric. Services revenue is primarily from FortiGuard security subscriptions and FortiCare technical support. At the end of 2021, products were 38% of revenue and services were 62% of sales. The California-based company sells products worldwide.
Read more on FTNT →About Smith & Nephew plc
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Read more on SNN →
